Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.

F Zannad; WG Stough; RJ Lipicky; J Tamargo; GL Bakris; JS Borer; Mde L Alonso García; S Hadjadj; W Koenig; S Kupfer; PA McCullough; O Mosenzon; S Pocock; AJ Scheen; Harald Sourij; B Van der Schueren; C Stahre; WB White; G Calvo

doi:10.1093/ehjcvp/pvw007

Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.

F Zannad
, WG Stough
, RJ Lipicky
, J Tamargo
, GL Bakris
, JS Borer
, Mde L Alonso García
, S Hadjadj
, W Koenig
, S Kupfer
, PA McCullough
, O Mosenzon
, S Pocock
, AJ Scheen
, Harald Sourij
, B Van der Schueren
, C Stahre
, WB White
, G Calvo

Research output: Contribution to journal › Review

35 Citations (Web of Science)

Original language	English
Journal	European Heart Journal - Cardiovascular Pharmacotherapy
DOIs	https://doi.org/10.1093/ehjcvp/pvw007
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

302 Clinical Medicine

DOI

10.1093/ehjcvp/pvw007

Links

Cite this

Zannad, F., Stough, WG., Lipicky, RJ., Tamargo, J., Bakris, GL., Borer, JS., Alonso García, M. L., Hadjadj, S., Koenig, W., Kupfer, S., McCullough, PA., Mosenzon, O., Pocock, S., Scheen, AJ., Sourij, H., Van der Schueren, B., Stahre, C., White, WB., & Calvo, G. (2016). Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion. European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvw007

@article{1d2c9804fcaa4f5498c6915bdf60f1f6,

title = "Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.",

author = "F Zannad and WG Stough and RJ Lipicky and J Tamargo and GL Bakris and JS Borer and \{Alonso Garc{\'i}a\}, \{Mde L\} and S Hadjadj and W Koenig and S Kupfer and PA McCullough and O Mosenzon and S Pocock and AJ Scheen and Harald Sourij and \{Van der Schueren\}, B and C Stahre and WB White and G Calvo",

year = "2016",

doi = "10.1093/ehjcvp/pvw007",

language = "English",

journal = "European Heart Journal - Cardiovascular Pharmacotherapy",

issn = "2055-6837",

publisher = "Oxford University Press",

}

Zannad, F, Stough, WG, Lipicky, RJ, Tamargo, J, Bakris, GL, Borer, JS, Alonso García, ML, Hadjadj, S, Koenig, W, Kupfer, S, McCullough, PA, Mosenzon, O, Pocock, S, Scheen, AJ, Sourij, H, Van der Schueren, B, Stahre, C, White, WB & Calvo, G 2016, 'Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.', European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvw007

TY - JOUR

T1 - Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.

AU - Zannad, F

AU - Stough, WG

AU - Lipicky, RJ

AU - Tamargo, J

AU - Bakris, GL

AU - Borer, JS

AU - Alonso García, Mde L

AU - Hadjadj, S

AU - Koenig, W

AU - Kupfer, S

AU - McCullough, PA

AU - Mosenzon, O

AU - Pocock, S

AU - Scheen, AJ

AU - Sourij, Harald

AU - Van der Schueren, B

AU - Stahre, C

AU - White, WB

AU - Calvo, G

PY - 2016

Y1 - 2016

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000383333300009

UR - https://pubmed.ncbi.nlm.nih.gov/27418973

UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC4907355

U2 - 10.1093/ehjcvp/pvw007

DO - 10.1093/ehjcvp/pvw007

M3 - Review

C2 - 27418973

SN - 2055-6837

JO - European Heart Journal - Cardiovascular Pharmacotherapy

JF - European Heart Journal - Cardiovascular Pharmacotherapy

ER -